NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/29/2022
Back to search
Official data from USPTO
PDMO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PDMO
ST13
US500000090406176Class
1, 5, 40, 42
Filing
90406176
Registration
6909412
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
11/29/2022
Trademark type
Word
Nice classes
1, 5, 40, 42
Filing date
12/23/2020
Registration date
11/29/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/29/2022
Last transaction
11/29/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Northumberland, GB
Examiner
BARRETT, LEAH N
Law office
L60
Current location
TMEG LAW OFFICE 106
Holders and representatives
Holders
Sterling Pharma Solutions Limited
Representatives
Sarah Anne Keefe WOMBLE BOND DICKINSON (US) LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Active chemical ingredients for use in the manufacture of pharmaceuticals for treating diabetesearnose and throat disordersepilepsygenetic disordershematological disordershormonal disordersinfectious diseaseslymphomametabolic disordersmouth and dental disordersmusculoskeletal disordernon-malignant disordernutritional disorderspainrare ophthalmological diseasesrare cancersrare infectious diseasesrare genetic diseasesrare respiratory diseasesrare central nervous system diseasesrare gastrointestinal diseasesrare immunological diseasesrare cardiovascular diseasesrare dermatological diseasesrare urinary system and sex hormone diseasesrare womens health diseasesrare earnosethroat diseasesanimal health disorderscardiovascular diseases and disorderscentral nervous system disordersdermatologic disordersendocrine system disordersgastrointestinal diseasesgenito urinary system and sex hormone imbalancesmale health disorderswomen's health disordersmental health disordersmusculoskeletal disordersrenal disorderscancerophthalmic disordersrenal diseasesrespiratory diseasestrauma and injury
Class 5
Pharmaceuticalspsychotropicsantihelminticsanti-infectiveslipid lowering agentsinducers of erectionsinduction agentsneuromuscular blocking agentssedativesanti-cancer medicationanti-inflammatoriesanti-fungalsanti-bacterialsanti-spasmodicsappetite stimulantsbronchodilatorsappetite suppressantsanti-convulsivesneuroprotective drugsanti-anxiety medicationanti-depressantsanti-ischemicsanti-psychotics; pharmaceutical preparations for treating diabetesearnose and throat disordersepilepsygenetic disordershematological disordershormonal disordersinfectious diseaseslymphomametabolic disordersmouth and dental disordersmusculoskeletal disordernon-malignant disordernutritional disorderspainrare ophthalmological diseasesrare cancersrare infectious diseasesrare genetic diseasesrare respiratory diseasesrare central nervous system diseasesrare gastrointestinal diseasesrare immunological diseasesrare cardiovascular diseasesrare dermatological diseasesrare urinary system and sex hormone diseasesrare womens health diseasesrare earnosethroat diseases; Pharmaceuticalspharmaceutical preparations and substances for the treatment of viralinfectiousmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders for medical or veterinary purposes; vaccines; medicine for treating diabetesearnose and throat disordersepilepsygenetic disordershematological disordershormonal disordersinfectious diseaseslymphomametabolic disordersmouth and dental disordersmusculoskeletal disordernon-malignant disordernutritional disorderspainrare ophthalmological diseasesrare cancersrare infectious diseasesrare genetic diseasesrare respiratory diseasesrare central nervous system diseasesrare gastrointestinal diseasesrare immunological diseasesrare cardiovascular diseasesrare dermatological diseasesrare urinary system and sex hormone diseasesrare womens health diseasesrare earnosethroat diseases; chemical preparations for use in the pharmaceutical industrynamely for treating diabetesearnose and throat disordersepilepsygenetic disordershematological disordershormonal disordersinfectious diseaseslymphomametabolic disordersmouth and dental disordersmusculoskeletal disordernon-malignant disordernutritional disorderspainrare ophthalmological diseasesrare cancersrare infectious diseasesrare genetic diseasesrare respiratory diseasesrare central nervous system diseasesrare gastrointestinal diseasesrare immunological diseasesrare cardiovascular diseasesrare dermatological diseasesrare urinary system and sex hormone diseasesrare womens health diseasesrare earnosethroat diseasesanimal health disorderscardiovascular diseases and disorderscentral nervous system disordersdermatologic disordersendocrine system disordersgastrointestinal diseasesgenito urinary system and sex hormone imbalancesmale health disorderswomen's health disordersmental health disordersmusculoskeletal disordersrenal disorderscancerophthalmic disordersrenal diseasesrespiratory diseasestrauma and injury
Class 40
Custom manufacture of pharmaceuticals; processing of pharmaceuticalsnamely treatment in the nature of chemical processing of chemicalbiochemical and pharmaceutical products for third parties; custom manufacturing services in the nature of processing of pharmaceutical preparations; processing of pharmaceutical preparationsassembly of products for othersprocessing of pharmaceuticalsmedicinesbiological preparations to the order and specification of others; treatment in the nature of chemical processing of chemicalbiochemical and pharmaceutical products for third parties; treatment of materialspharmaceuticalbiologicchemical products and their components used in the manufacture of pharmaceuticalsbiotherapeutic productsbiopharmaceuticals; treatment and destruction of pharmaceutical waste; informationadvice and consultancy services in relation to the aforesaid services
Class 42
Pharmaceutical research services; pharmaceutical drug development services; pharmaceutical design servicesshaping and designing pills; testing of pharmaceuticals; conducting clinical trials for others relating to pharmaceuticals and chemicals; pharmaceutical analysischemical composition analysistestinganalysisevaluation of pharmaceuticals to determine conformity with certification standards; pharmaceutical laboratory research services relating to pharmaceuticals; pharmaceutical product evaluation; inspection of pharmaceuticals; biological research services; quality control and authentication services for others in the field of pharmaceuticals; informationadvice and consultancy services in relation to the aforesaid services
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/29/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/13/2022
PUBO
PUBLISHED FOR OPPOSITION
09/13/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/24/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/02/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
08/02/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/02/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
08/02/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/02/2022
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
07/27/2022
PBER
WITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
07/27/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/22/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
07/19/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/19/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
07/19/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/19/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/30/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/30/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/30/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/24/2022
GNFR
FINAL REFUSAL E-MAILED
01/24/2022
CNFR
FINAL REFUSAL WRITTEN
01/24/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/28/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/28/2021
ALIE
ASSIGNED TO LIE
12/28/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/23/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/25/2021
GNRT
NON-FINAL ACTION E-MAILED
06/25/2021
CNRT
NON-FINAL ACTION WRITTEN
06/25/2021
DOCK
ASSIGNED TO EXAMINER
06/21/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/10/2021
NWAP
NEW APPLICATION ENTERED
12/26/2020
Continuous trademark protection
Get notified about every new filing that threatens PDMO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.